Phylogenetic analysis and subgenotypic distribution of the hepatitis B virus in Recife, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
Citação
INFECTION GENETICS AND EVOLUTION, v.14, p.195-199, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The analysis of the genomes of the hepatitis B virus in human hosts identifies phylogenetic variants called viral genotypes. Indeed, clinical and epidemiological observations suggest that differences in viral genotypes lead to distinct biological and clinical behaviors. The aim of this study was to evaluate the subgenotypic distribution and to conduct a phylogenetic analysis by Bayesian method of the hepatitis B virus (HBV) in patients from Recife, Brazil. From July 2009 to December 2010, 60 HBV infected patients were examined, 39 (65%) were males, whose mean age was 50 years old. 33 (55%) were genotyped by obtaining and amplifying a 1306 bp fragment comprising part of the DNA polymerase and the surface antigen of the HBV. The sequencing was performed on an ABI 3500 Automatic Sequencer and the consensus sequences were obtained by aligning both the sequenced strands (clockwise and anti-clockwise) using SEQUENCHER software. Phylogenetic analysis was conducted using the Markov Chain Monte Carlo simulation implemented by Bayesian evolutionary method by sampling trees. The following subgenotypic distribution was observed: A1 (79%), F2a (12%), A2 (6%) and F4 (3%) as was that those identified as subgenotype A1 were in the same cluster in the phylogenetic tree. In this study, the majority of patients presented the A1 subgenotype from the same viral strain. As per the distribution in the phylogenetic tree by Bayesian method, possibly this subgenotype was in the genetic make-up of Africans brought in centuries past to Brazil as slaves.
Palavras-chave
HBV genotype, HBV subgenotype, Phylogenetic analysis, Bayesian analysis, Hepatitis B virus
Referências
  1. Alcalde R, 2009, REV I MED TROP, V51, P269, DOI 10.1590/S0036-46652009000500006
  2. Almeida Delvone, 2006, Braz J Infect Dis, V10, P317
  3. Alvarado-Mora MV, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-415
  4. Alvarado Mora Mónica Viviana, 2011, Infect Genet Evol, V11, P103, DOI 10.1016/j.meegid.2010.10.003
  5. Alvarado Mora Mónica Viviana, 2010, J Gen Virol, V91, P501, DOI 10.1099/vir.0.015958-0
  6. Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642
  7. Becker Carlos Eduardo, 2010, Arq Gastroenterol, V47, P13, DOI 10.1590/S0004-28032010000100003
  8. Bertolini D.A., 2012, INFECT GENET EVOL
  9. Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761
  10. Carrilho FJ, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-13
  11. CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
  12. Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024
  13. Dias ALB, 2012, REV SOC BRAS MED TRO, V45, P9, DOI 10.1590/S0037-86822012000100003
  14. Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
  15. Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982
  16. Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1016/vir.0.19749-0
  17. Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x
  18. KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
  19. Matos MAD, 2009, T ROY SOC TROP MED H, V103, P899, DOI 10.1016/j.trstmh.2009.01.013
  20. Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103
  21. Mello FCD, 2012, MEM I OSWALDO CRUZ, V107, P317, DOI 10.1590/S0074-02762012000300005
  22. Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0
  23. Palumbo E, 2007, BRAZ J INFECT DIS, V11, P311, DOI 10.1590/S1413-86702007000300002
  24. Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
  25. Raimondi S, 2010, J HEPATOL, V52, P441, DOI 10.1016/j.jhep.2009.12.014
  26. Ribeiro NRC, 2006, LIVER INT, V26, P636, DOI 10.1111/j.1478-3231.2006.01280.x
  27. Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315
  28. Scheiblauer H, 2010, VOX SANG, V98, P403, DOI 10.1111/j.1423-0410.2009.01272.x
  29. Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5
  30. Teles SA, 1999, ARTIF ORGANS, V23, P1074, DOI 10.1046/j.1525-1594.1999.06310.x
  31. Tonetto PA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-149
  32. Valente F, 2010, MEM I OSWALDO CRUZ, V105, P970, DOI 10.1590/S0074-02762010000800004
  33. Yu H., 2010, INT J BIOMED IMAGING, V2010, P1